In mid-January, Spotify announced it will raise the monthly fee for its Individual Premium plan in the U.S. by approximately 8.3%, from $11.99 to $12.99. The company also adjusted pricing for Duo, Family and Student plans, reflecting increases of $1–$2 per account tier. Management cited rising content costs, continued investment in podcast and audiobook offerings, and the need to maintain healthy margins as drivers of the decision. With total Premium subscribers exceeding 215 million globally at year-end, Spotify expects the U.S. price hike alone to contribute an additional $400 million to $450 million in annual recurring revenue, partially offsetting greater royalty expenses and fueling further product development.

During the third quarter, Csenge Advisory Group increased its stake in Spotify by 277.8%, adding 2,317 shares to reach a total holding of 3,151 shares valued at $2.2 million as of its latest SEC filing. This follows several smaller positions established earlier in the year by Knuff & Co, Total Investment Management and Heartwood Wealth Advisors, each acquiring stakes worth roughly $27,000–$29,000. Sound Income Strategies also boosted its position by 156.3%, acquiring 25 additional shares, while GFG Capital initiated a new stake worth about $33,000. Institutional investors now own over 84% of Spotify’s outstanding shares, underscoring confidence in the company’s long-term growth prospects.

Spotify reported third-quarter revenue of $5.01 billion, up 7.1% year-over-year, and delivered adjusted earnings per share of $3.83, surpassing consensus estimates by nearly 105%. Advertiser revenue grew 15%, driven by programmatic sales and new self-serve tools, while Premium revenue rose 5% despite increasing promotional activity. Net margin expanded to 8.5%, and return on equity reached 21.7%. Following the update, analysts at UBS trimmed their price target from $850 to $800 but maintained a Buy rating, while Barclays lowered its target from $750 to $700 and kept an Overweight stance. Consensus among 34 analysts remains a Moderate Buy, with an average target implying mid-teens upside from current levels.